台灣泌尿科醫學會E-School

台灣泌尿科醫學會E-School

(PD9-6) Experimental research on the establishment and comparison of rat cavernous nerve forceps clamped and electrocoagulation injury model

2015-06-10 • 觀看: 2661 • 回應: 0 • doc
(PD9-5) Bdnf-hypersecreting human umbilical cord blood mesenchymal stem cells promote erectile function in a rat model of cavernous nerve electrocautery injury

2015-06-10 • 觀看: 2772 • 回應: 0 • doc
(PD9-4) Exploration of the association between dietary intake and endothelial function among vasculogenic erectile dysfunction population

2015-06-10 • 觀看: 2797 • 回應: 0 • doc
(PD9-3) The efficacy of increasing coital frequency in the treatment of premature ejaculation

2015-06-10 • 觀看: 2993 • 回應: 0 • doc
(PD9-2) Effect of tadalafil once daily on erectile function in patients after robotic assisted radical prostatectomy with bilateral nerve sparing

2015-06-10 • 觀看: 2859 • 回應: 0 • doc
(PD9-1) The effect of extracorporeal shock wave on cavernous nerve stimulation-induced intracavernous pressure increase in the diabetic rat

2015-06-10 • 觀看: 3454 • 回應: 0 • doc
(PD8-6) The Prognostic Value of Neutrophil And Lymphocyte Ratio in Patient Receiving Radical Cystectomy Operations

2015-06-04 • 觀看: 2690 • 回應: 0 • doc
(PD8-5) Is the calcified lesion of bladder wall after intravesical mitomycin-c therapy for superficial bladder cancer should be resected?

2015-06-04 • 觀看: 2887 • 回應: 0 • doc
(PD8-4) The predictive factors for concurrent renal pelvis tumor of patients with ureter carcinoma: kaohsiung chang gung memorial hospital experience.

2015-06-04 • 觀看: 2623 • 回應: 0 • doc
(PD8-3) Inferior survival, higher tumor recurrence and progression rates in primary non-muscle-invasive bladdercancer with impaired egfr

2015-06-04 • 觀看: 2769 • 回應: 0 • doc
(PD8-2) Hydronephrosis independently predicts worse outcome of upper tract urothelial carcinoma in patients presenting with simultaneous flank pain

2015-06-04 • 觀看: 2829 • 回應: 0 • doc
(PD7-6) Thrombomodulin expression regulates tumorigenesis in bladder cancer

2015-06-04 • 觀看: 2702 • 回應: 0 • doc